Global Parkinson's Disease Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Publication Month: Mar 2020 | No. of Pages: 128 Published By: Global Info Research
Single User License: US $ 3480
Corporate User License: US $ 6960

Market Overview
The global Parkinson's Disease Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.8% in the forecast period of 2020 to 2025 and will expected to reach USD 3008.5 million by 2025, from USD 2405.4 million in 2019.

The Parkinson's Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Parkinson's Disease Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Parkinson's Disease Therapeutics market has been segmented into:
Medications Therapeutics
Medical Devices Therapeutics

By Application, Parkinson's Disease Therapeutics has been segmented into:
Under 40 Years Old
40-65 Years Old
Above 65 Years Old

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Parkinson's Disease Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Parkinson's Disease Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Parkinson's Disease Therapeutics market.

The report offers in-depth assessment of the growth and other aspects of the Parkinson's Disease Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Parkinson's Disease Therapeutics Market Share Analysis
Parkinson's Disease Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Parkinson's Disease Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Parkinson's Disease Therapeutics sales, revenue and market share for each player covered in this report.

The major players covered in Parkinson's Disease Therapeutics are:
GSK
Kyowa Hakko Kirin Pharma
Teva Pharmaceutical
Novartis
Akorn
Boehringer Ingelheim
Desitin Arzneimittel
Merck
Abbvie
Astellas Pharma
Apokyn
US WorldMeds
Endo Pharmaceuticals
Orion
Valeant
F.Hoffmann-La Roche
Bausch Health
Stada Arzneimittel
H.Lundbeck

Table of Contents

1 Parkinson's Disease Therapeutics Market Overview
1.1 Product Overview and Scope of Parkinson's Disease Therapeutics
1.2 Classification of Parkinson's Disease Therapeutics by Type
1.2.1 Global Parkinson's Disease Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Type in 2019
1.2.3 Medications Therapeutics
1.2.4 Medical Devices Therapeutics
1.3 Global Parkinson's Disease Therapeutics Market by Application
1.3.1 Overview: Global Parkinson's Disease Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Global Parkinson's Disease Therapeutics Market by Regions
1.4.1 Global Parkinson's Disease Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Parkinson's Disease Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Parkinson's Disease Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Parkinson's Disease Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Parkinson's Disease Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Parkinson's Disease Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Parkinson's Disease Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Kyowa Hakko Kirin Pharma
2.2.1 Kyowa Hakko Kirin Pharma Details
2.2.2 Kyowa Hakko Kirin Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Kyowa Hakko Kirin Pharma SWOT Analysis
2.2.4 Kyowa Hakko Kirin Pharma Product and Services
2.2.5 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Teva Pharmaceutical
2.3.1 Teva Pharmaceutical Details
2.3.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Teva Pharmaceutical SWOT Analysis
2.3.4 Teva Pharmaceutical Product and Services
2.3.5 Teva Pharmaceutical Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Akorn
2.5.1 Akorn Details
2.5.2 Akorn Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Akorn SWOT Analysis
2.5.4 Akorn Product and Services
2.5.5 Akorn Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Boehringer Ingelheim SWOT Analysis
2.6.4 Boehringer Ingelheim Product and Services
2.6.5 Boehringer Ingelheim Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Desitin Arzneimittel
2.7.1 Desitin Arzneimittel Details
2.7.2 Desitin Arzneimittel Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Desitin Arzneimittel SWOT Analysis
2.7.4 Desitin Arzneimittel Product and Services
2.7.5 Desitin Arzneimittel Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck SWOT Analysis
2.8.4 Merck Product and Services
2.8.5 Merck Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Abbvie
2.9.1 Abbvie Details
2.9.2 Abbvie Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Abbvie SWOT Analysis
2.9.4 Abbvie Product and Services
2.9.5 Abbvie Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Astellas Pharma
2.10.1 Astellas Pharma Details
2.10.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Astellas Pharma SWOT Analysis
2.10.4 Astellas Pharma Product and Services
2.10.5 Astellas Pharma Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Apokyn
2.11.1 Apokyn Details
2.11.2 Apokyn Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Apokyn SWOT Analysis
2.11.4 Apokyn Product and Services
2.11.5 Apokyn Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.12 US WorldMeds
2.12.1 US WorldMeds Details
2.12.2 US WorldMeds Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 US WorldMeds SWOT Analysis
2.12.4 US WorldMeds Product and Services
2.12.5 US WorldMeds Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.13 Endo Pharmaceuticals
2.13.1 Endo Pharmaceuticals Details
2.13.2 Endo Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Endo Pharmaceuticals SWOT Analysis
2.13.4 Endo Pharmaceuticals Product and Services
2.13.5 Endo Pharmaceuticals Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.14 Orion
2.14.1 Orion Details
2.14.2 Orion Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Orion SWOT Analysis
2.14.4 Orion Product and Services
2.14.5 Orion Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.15 Valeant
2.15.1 Valeant Details
2.15.2 Valeant Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Valeant SWOT Analysis
2.15.4 Valeant Product and Services
2.15.5 Valeant Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.16 F.Hoffmann-La Roche
2.16.1 F.Hoffmann-La Roche Details
2.16.2 F.Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 F.Hoffmann-La Roche SWOT Analysis
2.16.4 F.Hoffmann-La Roche Product and Services
2.16.5 F.Hoffmann-La Roche Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.17 Bausch Health
2.17.1 Bausch Health Details
2.17.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Bausch Health SWOT Analysis
2.17.4 Bausch Health Product and Services
2.17.5 Bausch Health Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.18 Stada Arzneimittel
2.18.1 Stada Arzneimittel Details
2.18.2 Stada Arzneimittel Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Stada Arzneimittel SWOT Analysis
2.18.4 Stada Arzneimittel Product and Services
2.18.3 Stada Arzneimittel Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.19 H.Lundbeck
2.19.1 H.Lundbeck Details
2.19.2 H.Lundbeck Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 H.Lundbeck SWOT Analysis
2.19.4 H.Lundbeck Product and Services
2.19.5 H.Lundbeck Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Parkinson's Disease Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Parkinson's Disease Therapeutics Players Market Share
3.2.2 Top 10 Parkinson's Disease Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Parkinson's Disease Therapeutics Revenue and Market Share by Regions
4.2 North America Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Parkinson's Disease Therapeutics Revenue by Countries
5.1 North America Parkinson's Disease Therapeutics Revenue by Countries (2015-2020)
5.2 USA Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Parkinson's Disease Therapeutics Revenue by Countries
6.1 Europe Parkinson's Disease Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Parkinson's Disease Therapeutics Revenue by Countries
7.1 Asia-Pacific Parkinson's Disease Therapeutics Revenue by Countries (2015-2020)
7.2 China Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Parkinson's Disease Therapeutics Revenue by Countries
8.1 South America Parkinson's Disease Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Parkinson's Disease Therapeutics by Countries
9.1 Middle East & Africa Parkinson's Disease Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Parkinson's Disease Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Parkinson's Disease Therapeutics Market Forecast by Type (2019-2024)
10.3 Medications Therapeutics Revenue Growth Rate (2015-2025)
10.4 Medical Devices Therapeutics Revenue Growth Rate (2015-2025)
11 Global Parkinson's Disease Therapeutics Market Segment by Application
11.1 Global Parkinson's Disease Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Parkinson's Disease Therapeutics Market Forecast by Application (2019-2024)
11.3 Under 40 Years Old Revenue Growth (2015-2020)
11.4 40-65 Years Old Revenue Growth (2015-2020)
11.5 Above 65 Years Old Revenue Growth (2015-2020)
12 Global Parkinson's Disease Therapeutics Market Size Forecast (2021-2025)
12.1 Global Parkinson's Disease Therapeutics Market Size Forecast (2021-2025)
12.2 Global Parkinson's Disease Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Parkinson's Disease Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Parkinson's Disease Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Parkinson's Disease Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Parkinson's Disease Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Parkinson's Disease Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

Tables and Figures

List of Tables

Table 1. Global Parkinson's Disease Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Parkinson's Disease Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Parkinson's Disease Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Parkinson's Disease Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. GSK Corporate Information, Location and Competitors
Table 6. GSK Parkinson's Disease Therapeutics Major Business
Table 7. GSK Parkinson's Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. GSK SWOT Analysis
Table 9. GSK Parkinson's Disease Therapeutics Product and Solutions
Table 10. GSK Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Kyowa Hakko Kirin Pharma Corporate Information, Location and Competitors
Table 12. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Major Business
Table 13. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. Kyowa Hakko Kirin Pharma SWOT Analysis
Table 15. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product and Solutions
Table 16. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Teva Pharmaceutical Corporate Information, Location and Competitors
Table 18. Teva Pharmaceutical Parkinson's Disease Therapeutics Major Business
Table 19. Teva Pharmaceutical Parkinson's Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Teva Pharmaceutical SWOT Analysis
Table 21. Teva Pharmaceutical Parkinson's Disease Therapeutics Product and Solutions
Table 22. Teva Pharmaceutical Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Novartis Corporate Information, Location and Competitors
Table 24. Novartis Parkinson's Disease Therapeutics Major Business
Table 25. Novartis Parkinson's Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. Novartis SWOT Analysis
Table 27. Novartis Parkinson's Disease Therapeutics Product and Solutions
Table 28. Novartis Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Akorn Corporate Information, Location and Competitors
Table 30. Akorn Parkinson's Disease Therapeutics Major Business
Table 31. Akorn Parkinson's Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Akorn SWOT Analysis
Table 33. Akorn Parkinson's Disease Therapeutics Product and Solutions
Table 34. Akorn Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 36. Boehringer Ingelheim Parkinson's Disease Therapeutics Major Business
Table 37. Boehringer Ingelheim Parkinson's Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. Boehringer Ingelheim SWOT Analysis
Table 39. Boehringer Ingelheim Parkinson's Disease Therapeutics Product and Solutions
Table 40. Boehringer Ingelheim Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Desitin Arzneimittel Corporate Information, Location and Competitors
Table 42. Desitin Arzneimittel Parkinson's Disease Therapeutics Major Business
Table 43. Desitin Arzneimittel Parkinson's Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 44. Desitin Arzneimittel SWOT Analysis
Table 45. Desitin Arzneimittel Parkinson's Disease Therapeutics Product and Solutions
Table 46. Desitin Arzneimittel Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Merck Corporate Information, Location and Competitors
Table 48. Merck Parkinson's Disease Therapeutics Major Business
Table 49. Merck Parkinson's Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 50. Merck SWOT Analysis
Table 51. Merck Parkinson's Disease Therapeutics Product and Solutions
Table 52. Merck Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Abbvie Corporate Information, Location and Competitors
Table 54. Abbvie Parkinson's Disease Therapeutics Major Business
Table 55. Abbvie Parkinson's Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 56. Abbvie SWOT Analysis
Table 57. Abbvie Parkinson's Disease Therapeutics Product and Solutions
Table 58. Abbvie Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Astellas Pharma Corporate Information, Location and Competitors
Table 60. Astellas Pharma Parkinson's Disease Therapeutics Major Business
Table 61. Astellas Pharma Parkinson's Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 62. Astellas Pharma SWOT Analysis
Table 63. Astellas Pharma Parkinson's Disease Therapeutics Product and Solutions
Table 64. Astellas Pharma Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Apokyn Corporate Information, Location and Competitors
Table 66. Apokyn Parkinson's Disease Therapeutics Major Business
Table 67. Apokyn Parkinson's Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 68. Apokyn SWOT Analysis
Table 69. Apokyn Parkinson's Disease Therapeutics Product and Solutions
Table 70. Apokyn Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. US WorldMeds Corporate Information, Location and Competitors
Table 72. US WorldMeds Parkinson's Disease Therapeutics Major Business
Table 73. US WorldMeds Parkinson's Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 74. US WorldMeds SWOT Analysis
Table 75. US WorldMeds Parkinson's Disease Therapeutics Product and Solutions
Table 76. US WorldMeds Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Endo Pharmaceuticals Corporate Information, Location and Competitors
Table 78. Endo Pharmaceuticals Parkinson's Disease Therapeutics Major Business
Table 79. Endo Pharmaceuticals Parkinson's Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 80. Endo Pharmaceuticals SWOT Analysis
Table 81. Endo Pharmaceuticals Parkinson's Disease Therapeutics Product and Solutions
Table 82. Endo Pharmaceuticals Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Orion Corporate Information, Location and Competitors
Table 84. Orion Parkinson's Disease Therapeutics Major Business
Table 85. Orion Parkinson's Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 86. Orion SWOT Analysis
Table 87. Orion Parkinson's Disease Therapeutics Product and Solutions
Table 88. Orion Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Valeant Corporate Information, Location and Competitors
Table 90. Valeant Parkinson's Disease Therapeutics Major Business
Table 91. Valeant Parkinson's Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 92. Valeant SWOT Analysis
Table 93. Valeant Parkinson's Disease Therapeutics Product and Solutions
Table 94. Valeant Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. F.Hoffmann-La Roche Corporate Information, Location and Competitors
Table 96. F.Hoffmann-La Roche Parkinson's Disease Therapeutics Major Business
Table 97. F.Hoffmann-La Roche Parkinson's Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 98. F.Hoffmann-La Roche SWOT Analysis
Table 99. F.Hoffmann-La Roche Parkinson's Disease Therapeutics Product and Solutions
Table 100. F.Hoffmann-La Roche Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Bausch Health Corporate Information, Location and Competitors
Table 102. Bausch Health Parkinson's Disease Therapeutics Major Business
Table 103. Bausch Health Parkinson's Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 104. Bausch Health SWOT Analysis
Table 105. Bausch Health Parkinson's Disease Therapeutics Product and Solutions
Table 106. Bausch Health Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Stada Arzneimittel Parkinson's Disease Therapeutics Type and Application
Table 108. Stada Arzneimittel Parkinson's Disease Therapeutics Major Business
Table 109. Stada Arzneimittel Parkinson's Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 110. Stada Arzneimittel SWOT Analysis
Table 111. Stada Arzneimittel Parkinson's Disease Therapeutics Product and Solutions
Table 112. Stada Arzneimittel Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. H.Lundbeck Corporate Information, Location and Competitors
Table 114. H.Lundbeck Parkinson's Disease Therapeutics Major Business
Table 115. H.Lundbeck Parkinson's Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 116. H.Lundbeck SWOT Analysis
Table 117. H.Lundbeck Parkinson's Disease Therapeutics Product and Solutions
Table 118. H.Lundbeck Parkinson's Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. Global Parkinson's Disease Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 120. Global Parkinson's Disease Therapeutics Revenue Share by Players (2015-2020)
Table 121. Global Parkinson's Disease Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 122. Global Parkinson's Disease Therapeutics Revenue Market Share by Regions (2015-2020)
Table 123. North America Parkinson's Disease Therapeutics Revenue by Countries (2015-2020)
Table 124. North America Parkinson's Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Table 125. Europe Parkinson's Disease Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 126. Asia-Pacific Parkinson's Disease Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 127. South America Parkinson's Disease Therapeutics Revenue by Countries (2015-2020)
Table 128. South America Parkinson's Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Table 129. Middle East and Africa Parkinson's Disease Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 130. Middle East and Africa Parkinson's Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Table 131. Global Parkinson's Disease Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 132. Global Parkinson's Disease Therapeutics Revenue Share by Type (2015-2020)
Table 133. Global Parkinson's Disease Therapeutics Revenue Forecast by Type (2021-2025)
Table 134. Global Parkinson's Disease Therapeutics Revenue by Application (2015-2020)
Table 135. Global Parkinson's Disease Therapeutics Revenue Share by Application (2015-2020)
Table 136. Global Parkinson's Disease Therapeutics Revenue Forecast by Application (2021-2025)
Table 137. Global Parkinson's Disease Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Parkinson's Disease Therapeutics Picture
Figure 2. Global Parkinson's Disease Therapeutics Revenue Market Share by Type in 2019
Figure 3. Medications Therapeutics Picture
Figure 4. Medical Devices Therapeutics Picture
Figure 5. Parkinson's Disease Therapeutics Revenue Market Share by Application in 2019
Figure 6. Under 40 Years Old Picture
Figure 7. 40-65 Years Old Picture
Figure 8. Above 65 Years Old Picture
Figure 9. Global Parkinson's Disease Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Parkinson's Disease Therapeutics Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Parkinson's Disease Therapeutics Revenue Market Share in 2019
Figure 18. Global Top 10 Players Parkinson's Disease Therapeutics Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Parkinson's Disease Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 22. Global Parkinson's Disease Therapeutics Revenue Market Share by Regions in 2018
Figure 23. North America Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 24. Europe Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 26. South America Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. North America Parkinson's Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 29. North America Parkinson's Disease Therapeutics Revenue Market Share by Countries in 2019
Figure 30. USA Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 31. Canada Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 33. Europe Parkinson's Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Parkinson's Disease Therapeutics Revenue Market Share by Countries in 2019
Figure 35. Germany Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 36. UK Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 37. France Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 38. Russia Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. Italy Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Parkinson's Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Parkinson's Disease Therapeutics Revenue Market Share by Countries in 2019
Figure 42. China Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 43. Japan Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 44. Korea Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 45. India Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. South America Parkinson's Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 48. South America Parkinson's Disease Therapeutics Revenue Market Share by Countries in 2019
Figure 49. Brazil Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Parkinson's Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Parkinson's Disease Therapeutics Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 54. UAE Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. Global Parkinson's Disease Therapeutics Revenue Share by Type (2015-2020)
Figure 58. Global Parkinson's Disease Therapeutics Revenue Share by Type in 2019
Figure 59. Global Parkinson's Disease Therapeutics Market Share Forecast by Type (2021-2025)
Figure 60. Global Medications Therapeutics Revenue Growth Rate (2015-2020)
Figure 61. Global Medical Devices Therapeutics Revenue Growth Rate (2015-2020)
Figure 62. Global Parkinson's Disease Therapeutics Revenue Share by Application (2015-2020)
Figure 63. Global Parkinson's Disease Therapeutics Revenue Share by Application in 2019
Figure 64. Global Parkinson's Disease Therapeutics Market Share Forecast by Application (2021-2025)
Figure 65. Global Under 40 Years Old Revenue Growth Rate (2015-2020)
Figure 66. Global 40-65 Years Old Revenue Growth Rate (2015-2020)
Figure 67. Global Above 65 Years Old Revenue Growth Rate (2015-2020)
Figure 68. Global Parkinson's Disease Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Parkinson's Disease Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Parkinson's Disease Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Parkinson's Disease Therapeutics Revenue Market Forecast (2021-2025)
Figure 72. Europe Parkinson's Disease Therapeutics Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Parkinson's Disease Therapeutics Revenue Market Forecast (2021-2025)
Figure 74. South America Parkinson's Disease Therapeutics Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Parkinson's Disease Therapeutics Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel




Companies Mentioned
GSK
Kyowa Hakko Kirin Pharma
Teva Pharmaceutical
Novartis
Akorn
Boehringer Ingelheim
Desitin Arzneimittel
Merck
Abbvie
Astellas Pharma
Apokyn
US WorldMeds
Endo Pharmaceuticals
Orion
Valeant
F.Hoffmann-La Roche
Bausch Health
Stada Arzneimittel
H.Lundbeck

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets